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Effect of anthelmintic treatment on leptin, adiponectin and
leptin to adiponectin ratio: a randomized-controlled trial
DL Tahapary1,2,3,4, K de Ruiter2, I Martin5,6, EAT Brienen2, L van Lieshout2, Y Djuardi3,7, CC Djimandjaja3, JJ Houwing-Duistermaat5,8,
P Soewondo1,4, E Sartono2, T Supali3,7,11, JWA Smit9,10,11 and M Yazdanbakhsh2,11
Emerging evidence suggests that helminths might confer protection against the development of type 2 diabetes. We aimed to
assess the role of adipokines in mediating the effect of helminths on insulin resistance. Serum samples were obtained from a
randomized-controlled trial of anthelmintic treatment in an area endemic for soil-transmitted helminths (STH), Flores Island,
Indonesia. In STH-infected subjects, anthelmintic treatment signiﬁcantly increased the ratio of leptin to adiponectin (treatment
effect factor (95% conﬁdence interval (CI)), P-value for interaction: 1.20 (1.06–1.35), P= 0.010), which largely stemmed from a
signiﬁcant reduction in adiponectin (0.91 (0.85–0.98), P= 0.020) and a trend for an increase in leptin level (1.10 (1.00–1.21),
P= 0.119). No signiﬁcant effect on resistin level was observed. This increase in leptin to adiponectin ratio seemed to contribute to
the observed effect of deworming on increased insulin resistance (IR) as adjustment for leptin to adiponectin ratio attenuated the
effect on IR from 1.07 (1.01–1.14, P= 0.023) to 1.05 (0.99–1.11, P= 0.075). Anthelmintic treatment in STH-infected subjects increases
leptin to adiponectin ratio which may in small part contribute to the modest increase in IR. Further studies will be needed to assess
the effect of the changes in adipokine levels on the host immune response and metabolism.
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INTRODUCTION
Emerging evidence suggests that helminths might confer protec-
tion against the development of type 2 diabetes (T2D),1–5
presumably by modulating the host immune responses.6–8 Thus,
in addition to the more established risk factors, such as sedentary
lifestyle and high-energy foods, current deworming programs in
parallel with rapid socioeconomic development might potentially
contribute to the development of T2D in many low and middle-
income countries.6 In line with this, we have recently reported that
removal of helminth infections increases insulin resistance (IR),9
which is mainly mediated by the increase in adiposity,9 suggesting
a central role of adipose tissue (AT).10–13
Human AT secretes various adipokines, most notably leptin and
adiponectin, affecting metabolic homeostasis and immune
regulation.14 Leptin and adiponectin have been consistently
shown to be positively and negatively associated with IR,
respectively.14 Whereas leptin promotes pro-inﬂammatory
immune responses and inhibits the proliferation of regulatory
T cells, adiponectin induces the secretion of anti-inﬂammatory
cytokines.15 The imbalance between those two adipokines, leptin
to adiponectin (L/A) ratio, has been reported to be associated with
pro-inﬂammatory conditions and IR.16,17
Assessment of adipokines might provide a valuable insight into
the role of human AT in mediating the helminths effect on
metabolic homeostasis. To our knowledge, no studies have been
published so far on the association between helminth infections
and adipokines, except for resistin.18 Therefore, we measured
leptin, adiponectin, and resistin in serum samples obtained from a
randomized-controlled trial of anthelmintic treatment in an area
endemic for soil-transmitted helminth (STH).19 We hypothesized
that the increase in IR after anthelmintic treatment in helminth-
infected subjects might be mediated by a shift in L/A ratio towards
a more pro-inﬂammatory state.
MATERIALS AND METHODS
This present study is part of a household-based cluster-
randomized double-blind placebo-controlled anthelmintic trial
(The Sugarspin study), conducted in Nangapanda, Flores, an
endemic area for STH.19 The primary outcome of the Sugarspin
study is changes in IR, as assessed using the homeostatic model
assessment of IR (HOMA-IR), after anthelmintic treatment, which
has been published recently.9 Written informed consent was
obtained from all participants. The study was approved by the
ethics committee of Faculty of Medicine, Universitas Indo-
nesia (FKUI) (ref: 549/H2·F1/ETIK/2013), and ﬁled by the ethics
committee of Leiden University Medical Center (LUMC). The
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trial is registered as a clinical trial (http://www.isrctn.com/
ISRCTN75636394).
The population was randomized at household level. After
randomization, all subjects in the study area, except children o2
years old and pregnant women, received a single tablet of
albendazole (400 mg) or matching placebo for three consecutive
days with direct supervision. This three-monthly treatment regi-
men was given for four rounds. All subjects ⩾ 16 years old were
invited to undergo clinical measurements and blood drawing after
an overnight fast, at baseline and 6 weeks after the end of the
fourth treatment round (follow-up).19 All subjects without
sufﬁcient sera samples, and/or incomplete data on body mass
index and STH infection status at baseline were excluded from the
present study. Subjects receiving active treatment for diabetes
were also excluded from analysis.
Body weight and height were measured, and body mass index
was calculated as weight (kg) divided by square of height (m).
Adipokines (leptin, adiponectin and resistin) were measured by
ELISA using commercial reagents (DuoSet ELISA R&D System
Europe Ltd, Abingdon, UK), according to the manufacturer’s
protocol. Leptin to adiponectin (L/A) ratio was calculated by
L/A= leptin level (ng ml− 1)/adiponectin level (μg ml− 1).17 Soil-
transmitted helminth infection status was assessed using both
microscopy (Kato Katz) and PCR, which was further stratiﬁed by
the number of species a subject was infected with at baseline (no
infection, single infection, multiple infection).9
Statistical analysis
Leptin, adiponectin, L/A ratio and resistin were log-transformed
(log10) for analysis and summarized as geometric mean (95%
conﬁdence interval (CI)). The effect of anthelmintic treatment on
adipokine was assessed using mixed models to account for the
correlation within households, as described previously.9 The
treatment effect estimates were the regression coefﬁcient
obtained from mixed models (β) indicating changes in log10
(leptin, adiponectin, L/A ratio, resistin) of subjects using albenda-
zole compared with placebo. The treatment effect factors (10β) are
multiplicative instead of additive. Thus treatment effect factors
indicate the proportional change for each variable (leptin,
adiponectin, resistin, L/A ratio), in comparison to the placebo. All
models were ﬁtted using the lme4 package (R software x64
version 3.2.2 for Windows, R Foundation for Statistical Computing,
Vienna, Austria, www.r-project.org).
RESULTS
At baseline, the prevalence of STH infection was 42.0% (503/1195)
and 54.1% (760/1405), as assessed by microscopy and PCR,
Table 1. Study population
Placebo N=807 Albendazole N=750
Age (in years, mean, s.d.) 41.9 (15.4) 42.6 (15.5)
Sex (female %, n/N) 62.0 (500/807) 59.9 (449/750)
Body mass index (kg m−2, mean, s.d.) 22.5 (4.0) 22.5 (4.0)
Leptin to adiponectin ratio (geomean (95% CI)) 1.38 (1.25–1.53) 1.35 (1.21–1.51)
Leptin (ng ml− 1) (geomean (95% CI)) 7.1 (6.5–7.7) 6.7 (6.1–7.4)
Adiponectin (μg ml− 1) (geomean (95% CI)) 5.1 (4.9–5.4) 5.0 (4.7–5.3)
Resistin (ng ml− 1) (geomean (95% CI)) 15.6 (15.0–16.2) 15.7 (15.1–16.4)
Helminth-infected by microscopy (%, n/N) 43.5 (270/620) 40.5 (233/575)
Single species 28.2 (175/620) 26.4 (152/575)
Multiple species 15.3 (95/620) 14.1 (81/575)
Helminth-infected by PCR (%, n/N) 53.8 (392/729) 54.4 (368/676)
Single species 31.7 (231/729) 35.2 (238/676)
Multiple species 22.1 (161/729) 19.2 (130/676)
Abbreviation: CI, conﬁdence interval.
Figure 1. Effect of anthelmintic treatment on adiponectin, leptin, resistin, and leptin to adiponectin ratio in soil-transmitted helminth (STH)-
infected and uninfected subjects. The effect of anthelmintic treatment on adiponectin (ADI), leptin (LEP), resistin (RES) and leptin to
adiponectin ratio (L/A) in (a) STH-uninfected and (b) STH-infected subjects, as assessed by microscopy, are presented as proportion of changes
(95% CI) between pre and post treatment in the albendazole group compared with the placebo group which is set to zero. Adiponectin,
leptin, resistin and L/A ratio were log-transformed for analysis. Analysis was performed on 1183 subjects, after excluding 12 subjects with
diabetes. Treatment effect estimates were the regression coefﬁcient (β) obtained from mixed models indicating changes in log (ADI or LEP or
RES or L/A); the treatment effect factors (10β) are proportional instead of additive. Thus, treatment effect factors indicate the proportional
change in each variable in comparison to the placebo group. *Po0.05.
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respectively. Serum leptin, adiponectin, L/A ratio and resistin levels
were similar in both treatment arms (Table 1). The consort
diagram of the present study is shown in Supplementary Figure 1.
Similar to the main study, anthelmintic treatment signiﬁcantly
reduced the prevalence of STH infections, as assessed by
microscopy or PCR (Supplementary Table 1). In comparison to
placebo, albendazole treatment had no effect on adipokine levels
in subjects without STH infections (Figure 1a). In STH-infected
subjects, as assessed by microscopy, albendazole treatment
increased L/A ratio (treatment effect factor (95% CI): 1.20 (1.06–
1.35), P-value for interaction = 0.010), which was mostly derived
from a signiﬁcant reduction in adiponectin level (0.91 (0.85–0.98),
P= 0.020) and a trend for an increase in leptin level (1.10 (1.00–
1.21), P= 0.119) (Figure 1b). No signiﬁcant treatment effect on
resistin level was observed (1.00 (0.94–1.05), P= 0.363; Figure 1b)).
Pathway analysis showed that adjustment for changes in body
mass index partly attenuated the treatment effect on L/A ratio
(from 1.20 (1.06–1.35) to 1.13 (1.02 – 1.26), P= 0.040), which
translates from 20 to 13%. We also assessed whether the increase
in L/A ratio contributes to the increased IR after treatment in
helminth-infected subjects.9 This analysis showed that adjustment
for changes in L/A ratio, attenuated the treatment effect on IR
from 1.07 (1.01–1.14, P= 0.023) to 1.05 (0.99–1.11, P= 0.075), even
more than adjustment for changes in body mass index
(Supplementary Table 2).
When light infections were also considered by using PCR,
albendazole treatment did not signiﬁcantly increase L/A ratio (1.10
(1.00 –1.22), P= 0.321), despite a signiﬁcantly reduced adiponectin
level (0.94 (0.88–0.99), P= 0.060). No signiﬁcant treatment effect
was observed on the level of leptin, nor resistin (Supplementary
Figure 2). Next, we further stratiﬁed STH-infected subjects based
on the number of STH species a subject was infected with at
baseline. In subjects with multiple STH infections, albendazole
signiﬁcantly increased L/A ratio (1.25 (1.06–1.47), P= 0.042), which
derived from a signiﬁcant reduction in adiponectin level (0.88
(0.80–0.97), P= 0.015) and a non-signiﬁcant increase in leptin level
(1.10 (0.97–1.25), P= 0.463) (Supplementary Figure 3). Using
microscopy, a more pronounced reduction in adiponectin (0.90
(0.81–1.00), P= 0.041) was observed in subjects infected with
multiple STH species. The treatment effect on L/A ratio (1.15 (0.95–
1.39), P= 0.135) and leptin level (1.04 (0.90–1.20), P= 0.677) in
subjects infected with multiple species did not reach statistical
signiﬁcance (Supplementary Figure 4).
DISCUSSION
Our study is the ﬁrst to report the effect of anthelmintic treatment
on serum adipokine levels. In STH-infected subjects, treatment
signiﬁcantly increased L/A ratio, which has been reported to be
associated with low-grade inﬂammation16 and IR.16,17 The increa-
sed L/A ratio was derived by the signiﬁcant reduction in
adiponectin level, and to a lesser extent, a trend of increase in
leptin level. As adiponectin induces the secretion of anti-
inﬂammatory cytokines,15 while leptin increases Th1, suppresses
Th2, and can act as a negative signal for the proliferation of
human T regulatory cells,20 these changes may reverse the
helminth-associated type 2 and regulatory immune responses,
and presumably contribute to the development of IR. Indeed,
adjustment for the increase in L/A ratio attenuated the treatment-
associated increase in IR, observed in the main trial,9 even more
than adjustment for increase in body mass index. This suggests
that adipokines have a relatively more important role than the
adiposity in the mediation of helminth-associated beneﬁcial
effect on IR.
Using PCR, a more sensitive method, able to detect non-
clinically relevant STH infections, the treatment effects were less in
magnitude, as it signiﬁcantly reduced adiponectin level only, but
to a lesser extent. In line with this, in subjects with multiple STH
infections, associated with a higher infection intensity,9 treatment
resulted in more pronounced effects, namely a signiﬁcant
reduction in adiponectin level, a trend for increase in leptin level,
as well as a signiﬁcant increase in L/A ratio. Except for the effect
on adiponectin, these pronounced treatment effects were not
observed when infection was assessed by microscopy, which
might be due to the lower number of subjects who were found to
be infected with multiple species, when using microscopy.
Despite having an ideal study design to study the causal
relationship between helminth infections and adipokine levels,
and to assess the contribution of adipokine levels to the increased IR
after anthelmintic treatment, our study would have been more
complete if we would have assessed food intake, appetite, and
physical activity. In addition, measurements of other hormones that
inﬂuence metabolism, such as ghrelin and cortisol, as well as analysis
of AT biopsies and gut microbiome, could provide a more complete
overview on how helminths may modulate human metabolism.
In conclusion, anthelmintic treatment in STH-infected subjects
increases L/A ratio which may in small part contribute to the
increased IR. Further studies will be needed to assess the effect of
these changes in adipokine levels on the host metabolism and
modulation of the host immune responses.
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